SOYACAL 20% Drug Patent Profile
✉ Email this page to a colleague
When do Soyacal 20% patents expire, and what generic alternatives are available?
Soyacal 20% is a drug marketed by Alpha Thera and is included in one NDA.
The generic ingredient in SOYACAL 20% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for SOYACAL 20%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SOYACAL 20% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SOYACAL 20%
US Patents and Regulatory Information for SOYACAL 20%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpha Thera | SOYACAL 20% | soybean oil | INJECTABLE;INJECTION | 018786-001 | Jun 29, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |